Key stats
- Market cap
- 183B
- Open
- —
- Day range
- —
- 52-week range
- $35.12 – $64.16
- Volume
- 10.5M
- Avg volume
- 11.4M
NVO
Novo Nordisk$41.40+$0.75+1.85%Price as of Nov 13, 2026, 7:59 PM ET
Earnings
About
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
- Employees
- 69,500
- Headquarters
- Houston, TX